Relationship between cigarettes per day and hazard ratio (HR) for CVD and mortality outcomes: a cubic spline model evaluation. by Erfan Tasdighi (9144667)

Subjects:

Association between the number of cigarettes per day with cardiovascular outcomes among current cigarette users. by Erfan Tasdighi (9144667)

Subjects:

Cessation duration and pack-years concurrent effect on the hazard ratio (HR) for cardiovascular and mortality outcomes. by Erfan Tasdighi (9144667)

Subjects:

Association between smoking Status and Incidence of cardiovascular and mortality outcomes among women. by Erfan Tasdighi (9144667)

Subjects:

Loss of Vps34 is associated with decreased eTreg survival but intact activation. by Erienne G. Norton (9612079)

Loxoprofen and SB225002 administration decreased sound stress exposure-induced hyperalgesia. by Satoka Kasai (3861115)

“…Mice treated with loxoprofen (500 mg/kg) or SB225002 (3 mg/kg) showed significantly decreased response times to the filament compared to Stress + saline group (Stress + loxoprofen (500 mg/kg), 30 min after administration, **<i>P</i> < 0.01, 60 min after administration, ***<i>P</i><i> <i><</i> </i>0.001; Stress + SB225002 (3 mg/kg), 60 min after administration, *<i>P</i> < 0.05). 2-way ANOVA <i>post-hoc</i> Bonferroni test. …”

Table 1_Decreased neuronal excitability in hypertriglyceridemia hamsters with acute seizures.docx by Qiuyue Shen (20373266)

“…Following seizure induction, free palmitic acid levels in the frontal cortex dialysate significantly decreased, while the expression of palmitoyl acyltransferase 14 (ZDHHC14) in the frontal cortex tissue was higher in Apoc2^−/− hamsters than in wild-type hamsters. …”

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. by Kazuyoshi Ohkawa (836847)

Subjects:

S1 Data - by Kazuyoshi Ohkawa (836847)

Subjects:

Clinical course of patient no. by Kazuyoshi Ohkawa (836847)

Subjects:

Availability of modern family planning methods in 2014 and 2017. by Rajon Banik (12066099)

Subjects:

Facilities offering modern family planning services by division in 2014 (A) and 2017 (B). by Rajon Banik (12066099)

Subjects:

Facilities offering modern family planning services by survey years and facility types, 2014 and 2017. by Rajon Banik (12066099)

Subjects:

Factors associated with facility readiness for providing modern family planning services in 2014 and 2017. by Rajon Banik (12066099)

Subjects:

Modern family planning service readiness score by division in 2014 (A) and 2017 (B). by Rajon Banik (12066099)

Subjects:

Flowchart of the sample selection procedure from BHFS 2014 and 2017. by Rajon Banik (12066099)

Subjects: